S4 Ep3: Myfembree for moderate-to-severe endometriosis pain: Potential for adolescents - a podcast by Contemporary OB/GYN
from 2022-03-02T13:00
::
::
Contemporary OB/GYN® Associate Editor Lindsey Carr sat down with Jessica Shim, MD, an attending at in the Division of Gynecology, Department of Surgery, Boston Children’s Hospital; Harvard Medical School Boston, Massachusetts, to discuss Myfembree (relugolix, estradiol, and norethindrone acetate tablets; Myovant Sciences, Pfizer) and its possible approval in May 2022.
Further episodes of Pap Talk
Further podcasts by Contemporary OB/GYN
Website of Contemporary OB/GYN